BIA webinar recording: UK Leadership in AMR - driving international collaboration and new economic models

Watch the recording of the BIA UK Leadership in AMR webinar focused on driving international collaboration and new economic models.

Antimicrobial resistance (AMR) is an urgent global health threat. A study published in the Lancet in January estimated that in 2019, over one million people died from drug-resistant infections directly attributable to AMR.

Over the past year, the UK has played a key role in driving forward efforts to tackle AMR, including through the launch of its pilot project for an innovative subscription-style payment model for antimicrobials. The UK has also supported international efforts to increase funding for novel antimicrobials and promote stewardship in their use.

Chaired by Deborah O’Neil, CEO of NovaBiotics and BIA Board Member, an expert panel of speakers discuss the progress that has been made and the challenges that lie ahead.

Speakers:

Deborah O'Neil

Deborah O'Neil

Chief Executive Officer, NovaBiotics

Nick Crabb

Nick Crabb

Programme Director, Scientific Affairs, National Institute for Health and Care Excellence

Phil Packer

Phil Packer

Innovation Lead AMR and Vaccines, Innovate UK

Lizzy Molyneux

Lizzy Molyneux

Cystic Fibrosis Patient Representative

Candice King

Candice King

Cystic Fibrosis Patient Representative, The Cystic Fibrosis Trust

James Anderson

James Anderson

Executive Director of Global Health, IFPMA

 

More within